Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Dignitana 2020 Presentation - William Cronin, CEO Dignitana
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dignitana 2020 Presentation
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Exploring the Impact of Cutting Rates on Inflation
00:10:00
Latin Resources: Salinas Lithium Project Progress and Expansion Plans
00:10:00
Key Drivers and Strategies Shaping Värde Partners: Insights from Ilfryn Carstairs | Ilfryn Carstairs, CIO, Värde Partners.
00:10:00
Jake Klein, Executive Chair of Evolution Mining, discusses his journey and updates on Evolution's operations, including the Cowal Gold Mine, Ernest Henry, Mt Rawden, and Red Lake projects.|Jake Klein, Executive Chair of Evolution Mining,
00:10:00
Empowering Women in the Workplace: Career Insights from Anjie Peña Kallas and Abby Groom at T. Rowe Price
00:10:00
Geoscience INTEGRATOR: Your Comprehensive Mineral Exploration Data Solution | John McGaughey ,President of Mira Geoscience Ltd.
00:10:00
Setting Boundaries with Kyle Moore, CFP | Kyle Moore - FOUNDER, FINANCIAL PLANNER of Quarry Hill Advisors
00:10:00
Robert Strzelecki on TenderHut's Exciting Transition to Warsaw Stock Exchange’s Main Floor | Robert Strzelecki, CEO , TenderHut SA.
00:10:00
IMPROVED PATIENT OUTCOME|Shane Ray, Chief Marketing Officer,Curasan
00:10:00
Fortune Minerals Advances Critical Mineral Project with New Refinery and Funding Plans
00:10:00
EY Global CEO Carmine Di Sibio Discusses Strategic Spinoff and Consulting Growth | Carmine Di Sibio, CEO , Ernst & Young.
00:10:00
Roger Anderson on OmniTron Inc.'s Role in Water Remediation at the One-to-One Conference